| Application no. and date | 13782061.9 (espacenet) (Federated) (European Patent Register), 20130427 | | Patent/reg. no. and date | DK/EP 2841575, 20190626 | | Publication date | 20150304 | | Priority no. and date | US 201261639376 P, 20120427 | | EP pub. no. and date |
EP 2841575 20150304 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi, Osaka, JP | | Applicant ref. no. | P24454DKEP | | Inventor | O'KEEFE, Theresa, L., 20 Richgrain Avenue
Waltham, MA 02453, US,
FRANK, Helen, Alison, 7 Queens Circle
Sharon, MA 02067, US,
MCDONALD, Alice, A., 25 Swampscott Avenue
Swampscott, MA 01907, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | C07K 16/40 (2006.01) , G01N 33/574 (2006.01) | | Title | ANTI-GCC-ANTISTOFMOLEKYLER OG ANVENDELSE AF SAMME FOR AT TESTE SUSCEPTIBILITET OVERFOR GCC-TARGETERET TERAPI | | Int. application no. | US2013038542 | | Int. publication no. | WO2013163633 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
